key: cord-0953156-keb71cvg
authors: Zhang, Haocheng; Ai, Jing-Wen; Yang, Wenjiao; Zhou, Xian; He, Fusheng; Xie, Shumei; Zeng, Weiqi; Li, Yang; Yu, Yiqi; Gou, Xuejing; Li, Yongjun; Wang, Xiaorui; Su, Hang; Xu, Teng; Zhang, Wenhong
title: Metatranscriptomic Characterization of COVID-19 Identified A Host Transcriptional Classifier Associated With Immune Signaling
date: 2020-05-28
journal: Clin Infect Dis
DOI: 10.1093/cid/ciaa663
sha: 59cc297c007e31b70d6c68d9a11563f704fb792e
doc_id: 953156
cord_uid: keb71cvg

BACKGROUND: The recent identification of a novel coronavirus, also known as SARS-CoV-2, has caused a global outbreak of respiratory illnesses. The rapidly developing pandemic has posed great challenges to diagnosis of this novel infection. However, little is known about the metatranscriptomic characteristics of patients with Coronavirus Disease 2019 (COVID-19). METHODS: We analyzed metatranscriptomics in 187 patients (62 cases with COVID-19 and 125 with non-COVID-19 pneumonia). Transcriptional aspects of three core elements – pathogens, the microbiome, and host responses – were interrogated. Based on the host transcriptional signature, we built a host gene classifier and examined its potential for diagnosing COVID-19 and indicating disease severity. RESULTS: The airway microbiome in COVID-19 patients had reduced alpha diversity, with 18 taxa of differential abundance. Potentially pathogenic microbes were also detected in 47% of the COVID-19 cases, 58% of which were respiratory viruses. Host gene analysis revealed a transcriptional signature of 36 differentially expressed genes significantly associated with immune pathways such as cytokine signaling. The host gene classifier built on such a signature exhibited potential for diagnosing COVID-19 (AUC of 0.75-0.89) and indicating disease severity. CONCLUSIONS: Compared to those with non-COVID-19 pneumonias, COVID-19 patients appeared to have a more disrupted airway microbiome with frequent potential concurrent infections, and a special trigger host immune response in certain pathways such as interferon gamma signaling. The immune-associated host transcriptional signatures of COVID-19 hold promise as a tool for improving COVID-19 diagnosis and indicating disease severity.

An outbreak of serious pneumonias was first reported in Wuhan, China in December 2019 and spread rapidly globally [1] [2] [3] [4] . The causative infectious agent was a novel coronavirus, first named 2019-nCoV and then SARS-CoV-2 [1, 5, 6] . As of now, over 80,000 patients in China alone were diagnosed with novel coronavirus pneumonia (COVID-19) [2] .

The rapid spread of the COVID-19 pandemic internationally has created an urgent need for improved diagnosis and a better understanding of the infection [7, 8] .

SARS-CoV-2 is a highly transmissible and pathogenic respiratory virus [9] [10] [11] . Infected patients often present with a wide range of symptoms. Although most patients seem to have mild disease, ~20% may progress to severe illness, including pneumonia, respiratory failure, and even death [8, [12] [13] [14] . Recent reports have shown a correlation between poor clinical outcome and disease severity as indicated by oxygen saturation, respiratory rate, blood leukocyte/lymphocyte counts [12, [14] [15] [16] . However, little is understood about the molecular mechanisms underlying COVID-19's pathogenesis and prognosis.

Rapid identification of this novel virus at the beginning of the outbreak was achieved by recent advances in clinical metagenomics and metatranscriptomics for infectious diseases [6, 15, [17] [18] [19] . By extracting all nucleic acids from a patient's respiratory specimens and subjecting them to high-throughput next-generation sequencing (NGS), an unbiased collection of genomic and transcriptional profiles from pathogens, the microbiome, and the host cells is analyzed [20, 21] . This information can be used for taxonomic classification of known or novel microbes and analyses of host responses [19] .

In this study, we employed metatranscriptomic sequencing in 187 patients (62 with COVID-19 and 125 with non-COVID-19 pneumonias) to obtain unbiased, cross-organism transcriptional profiles. We aimed to characterize the three core elements of respiratory A c c e p t e d M a n u s c r i p t 7 infectionpathogens, the airway microbiome, and host responseand apply this information to facilitate better understanding and diagnoses of COVID-19.

An initial cohort of 113 pneumonia cases was enrolled in our study and classified based on the sample type and the status of infection. Of these, 38 COVID-19 cases were diagnosed based on clinical and epidemiologic evidence, and laboratory-confirmed by either RT-PCR or metatranscriptomic assay ( Figure 1 ). In this cohort, 60 samples were obtained by nasopharyngeal swabs (NS) (24 COVID-19 cases and 36 non-COVID-19 cases) and 53 samples of sputum (14 COVID-19 cases and 39 non-COVID-19 cases).

Among the 38 confirmed cases of COVID-19, metatranscriptomic sequencing and RT-PCR achieved the same sensitivity of 87% (33/38) and specificity of 100% (75/75). Despite the overall concordance between these two methods in diagnosis (91.2%, 103/113, Figure   2A ), 10 positive cases were missed by one of the two assays, implying of sample-dependent performance.

NGS read numbers mapped to the SARS-CoV-2 genome varied across 6 orders of magnitudes, with a median read number of 1,484, and a range of 2 to 19,016,501. The median genome coverage and sequencing depth was 46.8% (2.8%-100%) and 12.0× (1.0×-7870.1×), respectively ( Figure 2B ). The lengths of the viral genes were highly variable; ORF1a was the longest (21,290 bp) and ORF10 was the shortest (117 bp) [5, 22, 23] . Therefore, we measured the viral gene expression by transcript per million (TPM), which included normalization of the length of A c c e p t e d M a n u s c r i p t 8 each gene. As shown in Figure 2C , N and ORF10 had the highest expression, at a level of two-fold or more than most of the other viral genes. Orf1ab, commonly used as a target gene in PCR-based SARS-CoV-2 assays, had an expression level in the middle range, but showed the least variation in expression level. As high and consistent expression of detection targets would facilitate better sensitivity and reliability for diagnostic assays, these viral profiles indicate the potential of three genes as candidate targets for developing COVID-19 assays.

To fully characterize the microbial profiles in COVID-19, we constructed a database Table S1 ). We observed correlations between the abundance of certain species and C-A c c e p t e d M a n u s c r i p t 9 reactive protein levels, age, sex, and number of NGS reads mapped to the SARS-CoV-2 genome ( Figure S1 ).

To examine possible concurrent infections, we identified 24 microbes with potential pathogenicity in 18 of the 38 (47.4%) COVID-19 patients. These included 16 different microbial species, with Candida albicans and Human alphaherpesvirus 1 being the most frequently detected opportunistic pathogens, and 8 viral pathogens, such as Human influenza virus and Respiratory syncytial viruses ( Figure 3D ). We observed more potential coinfections with viruses (58%, 14/24) than with bacteria (25%, 6/24) or fungi (17%, 4/24).

These data imply that caution should be taken when ruling out COVID-19 in patients already diagnosed with other infections such as Human influenza virus.

In the non-COVID-19 pneumonia cases, we identified a differential spectrum of 76 microbes with pathogenic potential in 52% (39/75) of patients. Haemophilus parainfluenzae was the most frequently detected opportunistic pathogen and Rhinovirus C the most frequently detected pathogen ( Figure S2 ). Viral, bacterial, and fungal microbes accounted for 45% (34/76), 42% (32/76), and 13% (10/76) of cases, respectively.

To better understand the host transcriptional response to SARS-CoV-2 infection, we Table S2 and S3) .

Notably, almost all common DEGS, except for RNR1, showed significantly greater expression changes in SP than in NS, with an average fold change of 2.7 vs 1.8 (P<10 -4 , Figure 4B ). We also examined the expression of angiotensin converting enzyme 2 (ACE2) [26] [27] [28] [29] [30] , the receptor for SARS-CoV-2, but found no significant changes ( Figure S3 ).

We further performed gene set enrichment analysis with the common DEGs using the KEGG and Reactome databases, and identified 16 differential pathways, half related to immune signaling ( Figure 4C ). The immune system itself considered as a pathway was significantly overrepresented, with 12 differentially expressed genes (P<5×10 -6 ). Among the subcategories of immune signaling pathways, cytokine signaling was the most significantly deregulated, followed by innate immune system and neutrophil degranulation pathways ( Figure 4C, D) , indicating the critical roles of innate immune system and cytokine signaling in COVID-19 [31] [32] [33] [34] . Dysregulated expression of the interleukin-7 receptor (IL7R) and the interferon-gamma (IFN-γ) pathways (CIITA and HLA-DPB1 genes) were in line with previous reports of coronavirus infection [31] .

We next sought to build a predictive classifier based on the host transcriptional signature that could aid in COVID-19 diagnosis. These 36 conmen genes along with age and sex were We also categorized the COVID-19 subjects to test the potential of this host gene classifier to discern disease severity. We found a clear segregated clustering of severe and mild COVID-19 cases ( Figure 5C ). Inter-group comparison also revealed significant differences between non-COVID-19 and COVID-19 subjects, and between the mild and severe COVID-19 cases ( Figure 5D, P<0.001) .

A c c e p t e d M a n u s c r i p t 12 

In December 2019, a group of patients with pneumonia were identified as infected with a novel coronavirus, known as SARS-CoV-2, in Wuhan, China [1, 3] . Within a few months, COVID-19 aggressively spread to 79 countries and was declared a pandemic by the WHO in March 2020 [7] . SARS-CoV-2 is highly pathogenic and transmissible, and clinical characteristics of COVID-19 differ from those of SARS, MERS, and seasonal influenza [12, 14, 33] . Understanding the pathogenesis is COVID-19 is essential for improving its diagnosis and treatment.

To our knowledge, this is the first study characterizing the microbiome and host response by applying unbiased metatranscriptomic data in COVID-19. We applied RT-PCR and metatranscriptomic sequencing in a cohort of COVID-19 patients, and investigated the three core elements of acute respiratory infections: the pathogen, airway microbiome, and host response. We found reduced diversity in the airway microbiome and identified a host gene signature associated with COVID-19. We further defined a classifier based on such a signature to predict SARS-CoV-2 infection and disease severity.

Previous studies found SARS-CoV-2 made use of a densely glycosylated spike (S) protein to gain entry into host cells [28] . SARS-CoV-2 S binds with high affinity to host cell receptor-angiotensin-converting enzyme 2 (ACE2), a type I membrane protein expressed in lungs, heart, kidneys, and intestine [26] [27] [28] [29] 35] . However, the overall host-pathogen interaction network in SARS-CoV-2 infection remains largely unknown. Transcriptomic host heterogeneity has demonstrated its value for studying pathogenesis and disease prognosis in pneumonia [36, 37] . By harnessing an unbiased metatranscriptomic approach, we identified 36 host genes differentially expressed in COVID-19 subjects that were common in both NS and SP groups. For example, high-mobility-group protein B family-3 (HMGB3) was positively correlated with leukocyte and neutrophil counts, and negatively correlated with A c c e p t e d M a n u s c r i p t 13 viral load. Previous studies showed that HMGB is actively released in response to inflammatory stimuli and functions as a danger signal to activate immune responses [38] [39] [40] .

The HMGB family is expressed in almost all cell types, especially leukocytes. They transduce cellular signals by interacting with important inflammatory receptors such as TLR2 to activate the NF-κB, ERK and p38 pathways, and lead to cytokine production (TNF, IL-6 and IFN-γ) and greater cell survival [38] [39] [40] . Future studies are warranted to investigate the HMGB family's role as signaling molecules in COVID-19, especially in the process of cytokine secretion. To explore the potential cell-type specific effect, we also compared COVID-19 and non-COVID-19 cases within each sample type ( Figure S3 ). Despite overlap of many pathways in both groups, some pathways were specifically enriched by sample type.

For instance, the interferon pathway was significantly enriched in the COVID-19 cases in the NS group, which might reflect the viral responses of epithelial cells [41, 42] . Enrichment of the interleukin pathway was found in the SP samples, which might indicate viral responses of immune cells [43, 44] . Further studies to investigate the host responses in various cell types will be highly valuable to improve our understanding of COVID-19 pathogenesis.

Although various cytokines (e.g. IL7, tumor necrosis factor-α, TNFα, and IFNγ) have important roles in response to coronavirus infection [45, 46] , understanding of their local immune response in the respiratory tract, especially to SARS-CoV-2, remains very limited.

Our results showed even higher IFNγ signaling in COVID-19 cases comparison to non-COVID-19 pneumonias, suggesting that IFNγ may be one of the initial immune signals in response to SARS-CoV-2 infection.

By constructing a host gene classifier and assessing its differentiating performance, our results show promise for applying host transcriptional signatures to improve COVID-19

diagnosis and indicate disease severity. When the non-COVID-19 cases were categorized into four subgroups: viral, bacterial, clinically diagnosed infection with unknown pathogen A c c e p t e d M a n u s c r i p t 14 etiology or non-infection pneumonia, we found that the classifier was able to distinguish COVID-19 pneumonia from all forms of non-COVID-19 pneumonia, but could not differentiate among the non-COVID-19 forms ( Figure S7 ). In addition, we did pathway enrichment analyses between COVID-19 and each form of non-COVID-19 pneumonia.

Interestingly, among the top 20 differential pathways identified by individual comparisons, 13 were common, many related to immune signaling such as cytokine signaling, innate immune system and neutrophil degranulation ( Figure S8 ). Others have also reported that host transcriptome profiles held promise for diagnosing lower respiratory tract infections with an AUC of 0.88 (95% CI, 0.75-1.00) [37] . In addition, host transcriptional tools have been used to identify various acute respiratory viral infections. Moreover, certain transcriptomic signatures were associated with higher mortality in sepsis patients given corticosteroids, and may reflect immune response state and prognosis in those with severe sepsis [47] [48] [49] . Early identification of severely ill patients is essential in COVID-19 infections, where the median duration from ICU admission to death was 7 days (IQR 3-11) among patients who died [50] .

Earlier mechanical ventilation or use of antiviral agents may improve disease prognosis.

By harnessing unbiased metatranscriptomic sequencing, we characterized the transcriptional profiles of viral genes, microbiome, and host responses in a cohort of COVID-19 patients. Compared to those with non-COVID-19 pneumonia, we found that COVID-19 patients had a disrupted microbiome with further reduced alpha diversity in COVID-19, and a host gene signature associated with immune signaling. Based on such a signature, we built a host transcriptional classifier that displayed promising performance in diagnosing COVID-19 and indicating disease severity. Table S4 and Table S5 . There were no significant differences in sex or age between COVID-19 and non-COVID-19 cases.

Pneumonia patients were confirmed by chest CT before being enrolled into our study.

Among these patients, COVID-19 cases were diagnosed based on the WHO interim guidance [51] . According to Chinese guidelines [2] , suspected COVID-19 cases were identified as: (a) having pneumonia after a chest CT (with one of the two following criteria met: fever or respiratory symptoms, normal or decreased white blood cell counts, decreased lymphocyte counts), and (b) a travel history or contact with patients with fever or respiratory symptoms from Hubei Province or confirmed cases within 2 weeks. A confirmed COVID-19 case was defined as a positive SARS-COV-2 nucleic acid testing result either by RT-PCR or sequencing-based assay with respiratory specimens. Those who did not meet the clinical and epidemiologic criteria for suspected COVID-19 and also tested negative by metatranscriptomics and RT-PCR assays were defined as non-COVID-19 cases.

Severe cases were defined as having any one of the following: 1) Respiratory distress, respiratory rate ≥ 30 per minute; 2) Pulse oxygen saturation ≤ 93% on room air；and 3) oxygenation index (PaO 2 /FiO 2 ) ≤300 mmHg [12] . Oral or written consents were obtained A c c e p t e d M a n u s c r i p t 16 from all patients, and the study was approved by the ethics review committee of Huashan Hospital affiliated to Fudan University. Wilcoxon rank-sum test [52] . Species with differential abundance were identified within each group using DESeq2 in R at a false discovery rate (FDR)  0.1, fold change  2, and P  0.05.

Alpha diversity of the host transcriptional profile for each subject was assessed by SDI at the gene level using the Vegan package in R (version 3.4.0). SDIs between patients with and without SARS-CoV-2 infection were then compared within NS and SP samples separately using the Wilcoxon rank-sum test [52] . Differential expressed genes (DEGs) were identified in each group using DESeq2 in R with FDR  0.1, fold change  1.5, and P  0.05.

Gene set enrichment analysis was conducted using the Kobas program A c c e p t e d M a n u s c r i p t 18

Classifiers were built based on the 36 common DEGs and sample type, with or without age and sex as covariates. Elastic-net penalty logistic regression implementation from the Python-based sklearn module was used to generate receiver operating characteristic (ROC) and area under the curve (AUC) calculations, with a regularization parameter α of 0.5 and a six-fold cross-validation strategy [54] . Wilcoxon rank-sum tests were used for statistical assessment of differences in probability value in each group.

Statistical significance was defined as P < 0.05, using two-tailed tests of hypotheses unless indicated otherwise. Comparative analyses were conducted using Pearson χ2 tests,

Fisher's exact tests, Student's t-tests, or log-rank tests where appropriate as specified.

Raw microbial sequences are available via GISAID accession ID CNP0001055.

A c c e p t e d M a n u s c r i p t M a n u s c r i p t A c c e p t e d M a n u s c r i p t 30 Figure 5 

Coronaviruses: a paradigm of new emerging zoonotic diseases

National Health Commission of the People's Republic China

A novel coronavirus genome identified in a cluster of pneumonia cases-Wuhan

Evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as coronavirus disease 2019 (COVID-19) pandemic: A global health emergency

A pneumonia outbreak associated with a new coronavirus of probable bat origin

A novel coronavirus from patients with pneumonia in China

Latest rolling update: WHO characterizes COVID-19 as a pandemic

The Coronavirus Disease 2019 (COVID-19) Pandemic

Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia

Epidemiology of COVID-19

Pattern of early human-to-human transmission of Wuhan

Clinical characteristics of coronavirus disease 2019 in China

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China

Optimizing diagnostic strategy for novel coronavirus pneumonia, a multi-center study in Eastern China

Viral and host factors related to the clinical outcome of COVID-19

Actionable diagnosis of neuroleptospirosis by next-generation sequencing

Clinical metagenomic next-generation sequencing for pathogen detection

Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study

A highly multiplexed and sensitive RNA-seq protocol for simultaneous analysis of host and pathogen transcriptomes. Nature protocols

Dual RNA-seq of pathogen and host

Identification of novel subgenomic RNAs and noncanonical transcription initiation signals of severe acute respiratory syndrome coronavirus

The molecular biology of coronaviruses

Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia

Respiratory Disease following Viral Lung Infection Alters the Murine Gut Microbiota. Front Immunol

Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein

Insights into the Recent 2019 Novel Coronavirus (SARS-CoV-2) in Light of Past Human Coronavirus Outbreaks

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

The pathogenesis and treatment of the `Cytokine Storm' in COVID-19

COVID-19, immune system response, hyperinflammation and repurposing antirheumatic drugs

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

Dysregulation of immune response in patients with COVID-19 in Wuhan, China

SARS-CoV-2 and viral sepsis: observations and hypotheses

Transcriptomic profiling in childhood H1N1/09 influenza reveals reduced expression of protein synthesis genes. The Journal of infectious diseases

Integrating host response and unbiased microbe detection for lower respiratory tract infection diagnosis in critically ill adults

High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal

HMGB1 in health and disease

A core viral protein binds host nucleosomes to sequester immune danger signals

Differential Responses by Human Respiratory Epithelial Cell Lines to Respiratory Syncytial Virus Reflect Distinct Patterns of Infection Control

Influenza A Virus Infection Triggers Pyroptosis and Apoptosis of Respiratory Epithelial Cells through the Type I Interferon Signaling Pathway in a Mutually Exclusive Manner

Regulatory T cells in virus infections

Human virus-specific CD8+ T cells: diversity specialists

Coronavirus infections and immune responses

Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages

Blood Transcriptional Biomarkers for Active Tuberculosis among Patients in the United States: a Case-Control Study with Systematic Cross-Classifier Evaluation

Blood transcriptional signatures for tuberculosis diagnosis: a glass half-empty perspective

Transcriptomic Signatures in Sepsis and a Differential Response to Steroids. From the VANISH Randomized Trial

Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study

Clinical management of severe acute respiratory infection when Novel coronavirus (nCoV) infection is suspected: interim guidance. publications detail/clinical management of severe acute respiratory infection when novel coronavirus (ncov) infection is suspected

Gene Selection for Cancer Classification using Wilcoxon Rank Sum Test and Support Vector Machine

KOBAS 2.0: a web server for annotation and identification of enriched pathways and diseases. Nucleic acids research

Hands-On Machine Learning with Scikit-Learn, Keras, and TensorFlow: Concepts, Tools, and Techniques to Build Intelligent Systems

A c c e p t e d M a n u s c r i p t 20 A c c e p t e d M a n u s c r i p t